TCL1 expression predicts overall survival in patients with mantle cell lymphoma
Mantle cell lymphoma (MCL) has a heterogeneous clinical course. Although most cases show a poor prognosis, a minority has an indolent course. It is difficult to identify indolent MCL cases prospectively. T‐cell leukemia/lymphoma protein 1 (TCL1) is expressed by several B‐cell lymphomas, including MCL. This study examined the expression of TCL1 and its prognostic relevance for MCL.
No Supplementary Data
No Article Media
Document Type: Research Article
Publication date: December 1, 2015